ImClone Investigational Site

Udine 33100

0 studies enrolling now · 2 studies all time

What they study most

Adenocarcinoma, Gastric Cancer, Hepatocellular Carcinoma

Studies at this site

• Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma — Completed
• A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib — Completed